NCT07111416View on ClinicalTrials.gov

Personalizing A1c Using Hematologic Indices and CGM for Accurate Diabetes Diagnosis

Not yet recruitingOBSERVATIONAL

Enrollment

45

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

April 1, 2026

Study Completion Date

May 1, 2026

Conditions

Type 2 Diabetes

Sponsors

Collaborators (1)

Abbott Diabetes Care

All Listed Sponsors

collaborator

Abbott Diabetes Care

INDUSTRY

lead

Brigham and Women's Hospital

OTHER

NCT07111416 - Personalizing A1c Using Hematologic Indices and CGM for Accurate Diabetes Diagnosis | Biotech Hunter | Biotech Hunter